Advertisement
News
Subscribe to MDT Magazine News

Charles River pulls plug on $1.6B buy of WuXi

July 30, 2010 5:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Charles River Laboratories International Inc. has called off its planned $1.6 billion purchase of Chinese research firm WuXi PharmaTech (Cayman) Inc. The board of Wilmington-based Charles River Labs has instead authorized the company to buy back up to $500 million of its own stock.

BioScrip 2Q profit slides on buyout and taxes

July 30, 2010 4:45 am | by The Associated Press | Comments

BioScrip Inc.'s net income fell 29 percent in the second quarter, the pharmacy benefits manager said Friday, because of an acquisition and higher taxes.Earnings per share were shaved by a penny because of the company's buyout of Critical Homecare Solutions. The company reported a...

30 million women to benefit from health reform law

July 29, 2010 10:37 pm | by EurekAlert | Comments

(Commonwealth Fund) Thirty million women will benefit from the new health reform law over the next decade, either through new or strengthened insurance coverage, according to a new report from The Commonwealth Fund. The law will stabilize and reverse the growing exposure to health...

TOPICS:
Advertisement

Clinical trials can be improved by managing the learning curve

July 29, 2010 10:34 pm | by EurekAlert | Comments

(Duke University Medical Center) Researchers at Duke University Medical Center looked for a learning curve phenomenon in the data record of a large, multi-site clinical trial. Their findings point to ways to improve the quality of future trials through better training and simulation exercises.

TOPICS:

Transforaminal steroid injection for lumbar radicular pain proves superior to placebo

July 29, 2010 10:33 pm | by EurekAlert | Comments

(Wiley-Blackwell) A recent study from Australian researchers determined that transforaminal injection of steroids was a viable alternative to surgery for lumbar radicular pain due to disc herniation. Full details of the study appear in the August issue of Pain Medicine, a journal...

TOPICS:

Gen-Probe 2Q net income rises 42 percent on sales

July 29, 2010 4:45 pm | by The Associated Press | Comments

Diagnostic test maker Gen-Probe Inc. said Thursday its second-quarter net income jumped 42 percent on higher revenue from blood screening and women's health products.The company earned $28.1 million, or 57 cents per share, up from $19.8 million, or 38 cents per share, during the same period a...

TOPICS:

Western diet link to ADHD

July 29, 2010 12:38 pm | by EurekAlert | Comments

(Research Australia) A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a "Western-style" diet in adolescents. The research findings have just been published online in the international Journal of Attention Disorders. Leader...

TOPICS:

FDA CONSUMER HEALTH INFORMATION - Keep Kids, Pets Away From Skin Sprayed With Evamist

July 29, 2010 12:37 pm | by Bio-Medicine.Org | Comments

SILVER SPRING, Md. , July 29 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) says children and pets should not come in contact with Evamist, a topical drug for women used in the treatment of hot flashes caused by menopause. (Logo:...

TOPICS:
Advertisement

Launch of BioOptimalâ„¢ MF-SL Microfilters for Bioprocessing

July 29, 2010 12:37 pm | by Bio-Medicine.Org | Comments

TOKYO , July 29 /- Asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on August 1 of BioOptimal™ MF-SL, its new range of microfilters for bioprocessing applications. Designed specifically for use in cell culture clarification applications, BioOptimal™...

TOPICS:

Boston Scientific Announces FDA Approval of New Leads for the Precision Plusâ„¢ Spinal Cord Stimulator System

July 29, 2010 12:36 pm | by Boston Scientific | Comments

Company now offers pain specialists the most comprehensive portfolio of SCS percutaneous leads

TOPICS:

Evamist (estradiol transdermal spray): Drug Safety Communication - Unintended Exposure of Children and Pets to Topical Estrogen

July 29, 2010 12:31 pm | by U.S. Food & Drug Administration | Comments

Reports of adverse effects in children who may have been unintentionally exposed to the drug through skin contact with women using this product.

TOPICS:

Record results for Melexis in the second quarter of 2010

July 29, 2010 10:35 am | by I-Micronews | Comments

Intermediate declaration by the board of directors

Agios doubles staff, following Celgene deal

July 29, 2010 10:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Agios Pharmaceuticals Inc. has doubled in size following its deal with Celgene Corp., which was announced in April. The Cambridge-based company's head count now stands at around 45 workers, up from 22 before the deal, and Agios officials say the company will keep growing.

IRIDEX Announces Second Quarter 2010 Conference Call and Release Date

July 29, 2010 10:33 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif. , July 29 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that it will release its second quarter 2010 financial results after the market closes on Thursday, August 5, 2010 .  In conjunction with the release, the Company will host a conference call with...

TOPICS:

Endologix says FDA approves new stent

July 29, 2010 9:45 am | by The Associated Press | Comments

Medical device maker Endologix Inc. said Thursday it received Food and Drug Administration approval for its PowerFit Aortic Extensions stent.Stents are mesh-wire tubes that are used to prop arteries open after they have been surgically cleared of fatty plaque. The device is used in surgery to...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading